Stem cell transplantation safe for patients with HIV-associated lymphoma

Carfilzomib represents potent, effective addition to standard multiple myeloma therapy in phase III study

Post-transplant survival boosted by brentuximab vedotin in lymphoma

Brentuximab vedotin prolongs post-transplant survival in hard-to-treat lymphoma patients in phase III study

Children with aggressive leukaemia experiencing remission with T cell therapy

ASPIRE study: Carfilzomib potent addition to multiple myeloma therapy

Overall survival update from the BREAK-3 study

ecancermedicalscience editor's choice for November 2014

Biomarker for PARP inhibitor responsiveness in ovarian cancer patients

New drug, ASP8273, shows response in Japanese patients with treatment-resistant non-small cell lung cancer

New emerging treatments and challenges in MCL, MM and CLL: Expert panel discussion

Early events found to trigger lung cancer twenty years before diagnosis